These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15202777)

  • 21. The dopamine beta-hydroxylase inhibitor nepicastat increases dopamine release and potentiates psychostimulant-induced dopamine release in the prefrontal cortex.
    Devoto P; Flore G; Saba P; Bini V; Gessa GL
    Addict Biol; 2014 Jul; 19(4):612-22. PubMed ID: 23289939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tyrosine depletion lowers dopamine synthesis and desipramine-induced prefrontal cortex catecholamine levels.
    Bongiovanni R; Newbould E; Jaskiw GE
    Brain Res; 2008 Jan; 1190():39-48. PubMed ID: 18082673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of medial prefrontal cortex dopamine by alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptors.
    Wu WR; Li N; Sorg BA
    Neuroscience; 2002; 114(2):507-16. PubMed ID: 12204218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypothalamic infusion of amphetamine increases serotonin, dopamine and norepinephrine.
    Parada M; Hernandez L; Schwartz D; Hoebel BG
    Physiol Behav; 1988; 44(4-5):607-10. PubMed ID: 2853386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of desipramine and amphetamine on noradrenergic neurotransmission: electrophysiological studies in the rat brain.
    Curet O; De Montigny C; Blier P
    Eur J Pharmacol; 1992 Oct; 221(1):59-70. PubMed ID: 1333978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioural and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat.
    Carter CJ; Pycock CJ
    Brain Res; 1980 Jun; 192(1):163-76. PubMed ID: 7189685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of zotepine on dopamine, serotonin and noradrenaline release in rat prefrontal cortex.
    Nakamura S; Ago Y; Itoh S; Koyama Y; Baba A; Matsuda T
    Eur J Pharmacol; 2005 Dec; 528(1-3):95-8. PubMed ID: 16321379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Local 5HT3 receptors mediate fluoxetine but not desipramine-induced increase of extracellular dopamine in the prefrontal cortex.
    Tanda G; Frau R; Di Chiara G
    Psychopharmacology (Berl); 1995 May; 119(1):15-9. PubMed ID: 7675944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential alpha-mediated inhibition of dopamine and noradrenaline release in the parietal and occipital cortex following noradrenaline transporter blockade.
    Valentini V; Cacciapaglia F; Frau R; Di Chiara G
    J Neurochem; 2006 Jul; 98(1):113-21. PubMed ID: 16805801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats.
    Shoblock JR; Sullivan EB; Maisonneuve IM; Glick SD
    Psychopharmacology (Berl); 2003 Feb; 165(4):359-69. PubMed ID: 12491026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced serotonin and dopamine release in rat medial prefrontal cortex.
    Kuroki T; Ichikawa J; Dai J; Meltzer HY
    Brain Res; 1996 Dec; 743(1-2):357-61. PubMed ID: 9017269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased dopamine and norepinephrine release in medial prefrontal cortex induced by acute and chronic stress: effects of diazepam.
    Finlay JM; Zigmond MJ; Abercrombie ED
    Neuroscience; 1995 Feb; 64(3):619-28. PubMed ID: 7715775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple, small dose administration of (-)deprenyl enhances catecholaminergic activity and diminishes serotoninergic activity in the brain and these effects are unrelated to MAO-B inhibition.
    Knoll J; Miklya I
    Arch Int Pharmacodyn Ther; 1994; 328(1):1-15. PubMed ID: 7893186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative in vitro studies on noradrenaline uptake and its inhibition by amphetamine, desipramine and chlorpromazine.
    Häggendal J; Hamberger B
    Acta Physiol Scand; 1967; 70(3):277-80. PubMed ID: 4293470
    [No Abstract]   [Full Text] [Related]  

  • 35. Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex.
    Lindefors N; Barati S; O'Connor WT
    Brain Res; 1997 Jun; 759(2):205-12. PubMed ID: 9221938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of methamphetamine on single unit activity in rat medial prefrontal cortex in vivo.
    Jang J; Ha HJ; Kim YB; Chung YK; Jung MW
    Neural Plast; 2007; 2007():29821. PubMed ID: 18288241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulation of the locus coeruleus elicits noradrenaline and dopamine release in the medial prefrontal and parietal cortex.
    Devoto P; Flore G; Saba P; Fà M; Gessa GL
    J Neurochem; 2005 Jan; 92(2):368-74. PubMed ID: 15663484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of serotonin 2A receptors in the D-amphetamine-induced release of dopamine: comparison with previous data on alpha1b-adrenergic receptors.
    Auclair A; Blanc G; Glowinski J; Tassin JP
    J Neurochem; 2004 Oct; 91(2):318-26. PubMed ID: 15447665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Possible involvement of medial prefrontal cortex in amphetamine-induced sensitization of mesolimbic dopamine function.
    Banks KE; Gratton A
    Eur J Pharmacol; 1995 Aug; 282(1-3):157-67. PubMed ID: 7498271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered responsiveness of medial prefrontal cortex neurons to glutamate and dopamine after withdrawal from repeated amphetamine treatment.
    Peterson JD; Wolf ME; White FJ
    Synapse; 2000 Jun; 36(4):342-4. PubMed ID: 10819912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.